Insulin-like Growth Factor-Binding Protein 2 in Severe Aortic Valve Stenosis and Pulmonary Hypertension: A Gender-Based Perspective
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25158220 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Elke Boxhammer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine II, Division of Cardiology, Paracelsus Medical University of Salzburg, 5020 Salzburg, Austria. Hauptthemen laut MEDLINE: Aortic Valve Stenosis, Hypertension, Pulmonary, Insulin-Like Growth Factor Binding Protein 2. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Severe aortic valve stenosis (AS) and pulmonary hypertension (PH) are life-threatening cardiovascular conditions, necessitating early detection and intervention. Recent studies have explored the role of Insulin-like Growth Factor-Binding Protein 2 (IGF-BP2) in cardiovascular pathophysiology. Understanding its involvement may offer novel insights into disease mechanisms and therapeutic targets for these conditions. A total of 102 patients (46 female, 56 male) with severe AS undergoing a transcatheter aortic valve replacement (TAVR) in a single-center study were classified using echocardiography tests to determine systolic pulmonary artery pressure (sPAP) and the presence (sPAP ≥ 40 mmHg) or absence (sPAP < 40 mmHg) of PH. Additionally, serial laboratory determinations of IGF-BP2 before, and at 24 h, 96 h, and 3 months after intervention were conducted in all study participants. Considering the entire cohort, patients with PH had significant and continuously higher serum IGF-BP2 concentrations over time than patients without PH. After subdivision by sex, it could be demonstrated that the above-mentioned results were only verifiable in males, but not in females. In the male patients, baseline IGF-BP2 levels before the TAVR was an isolated risk factor for premature death after intervention and at 1, 3, and 5 years post-intervention. The same was valid for the combination of male and echocardiographically established PH patients. The predictive role of IGF-BP2 in severe AS and concurrent PH remains unknown. A more profound comprehension of IGF-BP2 mechanisms, particularly in males, could facilitate the earlier consideration of the TAVR as a more effective and successful treatment strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine II, Division of Cardiology, Paracelsus Medical University of Salzburg, 5020 Salzburg, Austria.
ORCID-Profile: Elke Boxhammer, Vera Paar, Kristen Kopp, Richard Rezar, Moritz Mirna
Zitieren
APA
Boxhammer, E., Paar, V., Kopp, K., Gharibeh, S. X., Bovenkamp-Aberger, E., Rezar, R., Lichtenauer, M., Hoppe, U. C., & Mirna, M. (2024). Insulin-like Growth Factor-Binding Protein 2 in Severe Aortic Valve Stenosis and Pulmonary Hypertension: A Gender-Based Perspective. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25158220
Vancouver
Boxhammer E, Paar V, Kopp K, Gharibeh SX, Bovenkamp-Aberger E, Rezar R, et al. Insulin-like Growth Factor-Binding Protein 2 in Severe Aortic Valve Stenosis and Pulmonary Hypertension: A Gender-Based Perspective. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25158220
BibTeX
@article{Boxhammer2024,
author = {Boxhammer, Elke and Paar, Vera and Kopp, Kristen and Gharibeh, Sarah X and Bovenkamp-Aberger, Evelyn and Rezar, Richard and Lichtenauer, Michael and Hoppe, Uta C and Mirna, Moritz},
title = {Insulin-like Growth Factor-Binding Protein 2 in Severe Aortic Valve Stenosis and Pulmonary Hypertension: A Gender-Based Perspective},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25158220}
}
EUVIMED